rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler chartwell rx, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 3 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-901
Product ID 62135-901_070bd281-9772-c587-e063-6294a90a04a2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207797
Listing Expiration 2026-12-31
Marketing Start 2017-09-28

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135901
Hyphenated Format 62135-901

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0362135901608 0362135903602 0362135902605 0362135900601
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA207797 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (62135-901-60)
source: ndc

Packages (1)

62135-901-60 60 CAPSULE in 1 BOTTLE (62135-901-60)

Ingredients (1)

rivastigmine tartrate (3 mg/1)

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "070bd281-9772-c587-e063-6294a90a04a2", "openfda": {"upc": ["0362135901608", "0362135903602", "0362135902605", "0362135900601"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["2bb5e0d6-f677-4021-9888-3ff90979ef7d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (62135-901-60)", "package_ndc": "62135-901-60", "marketing_start_date": "20230104"}], "brand_name": "Rivastigmine Tartrate", "product_id": "62135-901_070bd281-9772-c587-e063-6294a90a04a2", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "62135-901", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "3 mg/1"}], "application_number": "ANDA207797", "marketing_category": "ANDA", "marketing_start_date": "20170928", "listing_expiration_date": "20261231"}